| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |